·
×
This browser does not support the video element.
No Source!
Private
Like
Bookmark
Share
facebook
linkedin
twitter
reddit
pinterest
email
Whatsapp
Related
PAH
vs. heart failure ... #Hypertension #
PAH
... #Comparison #
Table
Summary
table
of ... medical diagrams,
tables
... #pharmacology #
table
... #medications #
treatment
Lab
patterns seen ... Metabolism A
table
... of
lab
values compiled ... Peds #Pediatrics #
Table
Comorbidities: •
Stable
... Opioid Withdrawal,
PAD
... #pharmacology #
table
Tobacco Cessation
Treatment
... , Varenicline (
tablet
... release (SR) (
tablet
... Therapy #Comparison #
Table
Treatment
Algorithm ... #Hypertension #
PAH
... #
Treatment
#Management
Pharmacologic
Treatment
... Hyperthyroidism #
Treatment
... Medications #Comparison #
Table
►
Summary
Table
of ...
Causes
of Acrocyanosis ... #Differential #
Causes
... #Diagnosis #
Causes
... #
Table
Guidelines for
Treatment
... Polyarteritis Nodosa (
PAN
... pubmed.ncbi.nlm.nih.gov/34235884/
PAN
... Vasculitis #Management #
Treatment
DOACs) for VTE
treatment
... prevention - Comparison
Table
... Pharmacology #Comparison #
Table
Occult
Causes
of ... hypotension is
treatment
... response -> cognitive
pause
... toxicologic - 2nd
cause
... #Differential #
Causes
eyelash follicle •
Cause
... , swelling •
Treatment
... upper lid •
Cause
... painless lump •
Treatment
... Chalazion #Comparison #
Table
#Differential #
Table
... #Dyspnea #SOB #
Causes
Table
of
Causes
... Liver #Injury #
Causes
... Differential #Incidence #
Table
Pharmacologic
Treatments
... Pregnancy #Management #
Treatment
... Pharmacology #HTN #
Table
ligament
PAF
... process fracture •
Par
... fractures: Don't
cause
... deficit, still
able
... Cauda equina
Treatment
Causes
of Frequency ... Nocturia #Polyuria #
Causes
... Differential #Urology #
Table
conditions all of which
cause
... different types/
causes
... RenalTubularAcidosis #Features #
Table
antibiotic in-hospital
treatment
... antibiotics #therapy #
treatment
... #
table
#duration
Causes
of Cough ... , Chemicals,
Gases
... #Differential #
Causes
... #
Table
REBEL Review 89:
Treatment
... Hemorrhage #FOAMed #
table
Room - Comparison
Table
... Labs, Imaging and
Treatment
... BiliaryDiseases #
Table
See the
lab
values ...
table
for supplemental ... Peds #Pediatrics #
Table
Antiarrhythmic Medication
Table
... #Medications #
Table
... Classification #
Classes
Differential #Diagnosis #
Table
... #
Causes
#pharmacology #
table
... comparison #drugs #
treatment
Differential #Diagnosis #
Table
... #OrganSystem #
Causes
Diagnosis of Common
Causes
... Diagnosis #Comparison #
Table
- A Comparison
Table
... Diagnosis and
Treatment
... Vein #Comparison #
Table
Causes
of Pleural ... #Differential #
Table
Clues
to Differential ... Central #Cardiology #
Causes
... #
Table
#Comparison
#Asthmaticus #
Treatment
... #Options #
Table
Drugs Used for the
Treatment
... #Medications #
Treatment
... #Pharmacology #
Table
of diseases can
cause
... headaches are
caused
... Primary #Secondary #
Table
high WBC count
cause
... or priapism •
Lab
... organ damage •
Treatment
... Low calcium •
Treatment
... - Hyperkalemia
treatment
Features of Major
Causes
... Symptoms #Comparison #
Table
Causes
of Thrombocytopenia ... practices that could
cause
... HCV testing -
Lab
... patients if the
cause
... Differential #Diagnosis #
Causes
Treatment
of Bleeding ... HemophiliaB #Management #
Table
... #
Treatment
Life Threatening
Causes
... Differential Diagnosis
Table
... differential #diagnosis #
table
Causes
, Symptoms ... Diagnosis #Comparison #
Table
►
Ab
to AChR blocks ... muscles: “myasthenic
crises
... Miller Fischer and
PCB
... - Symptomatic
Treatment
... Myasthenia
Crises
#pharmacology #
table
... comparison #management #
treatment
#Differential #
Causes
... #
Table
Reflex Testing -
Causes
... Deep coma (any
cause
... Hyperreflexia #Testing #
Causes
... differential #diagnosis #
table
Fluid in Different
Causes
... Viral #Comparison #
Table
Hypertension (
PAH
... #Hypertension #
PAH
... Management #Algorithm #
treatment
REBEL Review 71:
Treatment
... hyperthyroidism #
table
... #management #
treatment
classification Different
causes
... Tertiary #Comparison #
Table
#pharmacology #
table
... comparison #management #
treatment
Inpatient Cath
Lab
... Indications Cath
Lab
... arrhythmia Cath
lab
... -7) risk Cath
lab
... Rx: NSTEMI/UA:
stable
#management #
treatment
... #
table
#Pharmacology #
Treatment
... #
Table
#Medications
Treatment
of
Stable
... Treat underlying
cause
... Treat underlying
cause
... #
Stable
#NarrowComplex ... #Tachycardia #
Treatment
Common
Causes
of ... Lightheadedness #
Table
ILD of Known
Cause
... Pneumonitis •
Treatment
... BrighamChiefs #ILD #
Causes
Differential Diagnosis
Table
... whether AF is
cause
... Tx: Underlying
cause
... Differential #Diagnosis #
Table
... Narrow #Irregular #
causes
Table
of Weight-Loss ... the long-term
treatment
... #Pharmacology #
Table
Organisms and
Treatment
... Bacterial #Meningitis #
Causes
Syndromes - This
table
... some toxicologic
causes
... Syndromes #Comparison #
Table
#Differential #
Table
... #
Causes
#Intrahepatic
Hyperthermia (most common
cause
... No confirmatory
lab
... Cornerstone of
treatment
It is
caused
by ... actually seen in all
causes
... pneumonia, congenital
causes
... Devpriyo
Pal
@drdevrad
Causes
of AKI in ... Differential #Diagnosis #
Causes
... #
table
Polyarteritis Nodosa (
PAN
... @MithuRheum #
PAN
... Vasculitis #Management #
Treatment
Brief Overview of
Treatment
... #Medications #
Treatment
... #Pharmacology #
Table
The anterior fat
pad
... posterior fat
pad
... So even in a
case
... posterior fat
pad
... the anterior fat
pad
Diagnosis #Nephrology #
Table
... #Differential #
Causes
(from multiple
causes
... pseudofracture -
Lab
... of underlying
cause
... Osteopenia -
Lab
Differential #Diagnosis #
Causes
... #
Table
• Most common
cause
... antibiotics once
stable
... hemorrhage •
Treatment
... shows a small,
stable
... #differential #
causes
Cyanide Toxicity
Treatment
... Amyl nitrite -
causes
... Pathophysiology #Management #
Treatment
Ioxedes Tick -
Treatment
... Lone Star Tick -
Treatment
... Ioxedes Tick -
Treatment
... diagnosis #comparison #
table
Medications #Management #
Treatment
... #Pharmacology #
Table
Diagnosis and
Treatment
... of Common
Causes
Underlying
causes
... Differential #Diagnosis #
Table
the therapeutic
uses
... adrenergic agonists
Table
... and Therapeutic
Uses
... #Alpha #Beta #
Table
distinction has HUGE
treatment
... and first-line
treatment
... Comparison #Diagnosis #
Table
CAH #algorithm #
causes
... diagnosis #comparison #
treatment
Causes
of Terminal ... Vascular: SLE,
PAN
... Differential #Diagnosis #
Causes
arrest where other
causes
... trolley, anaphylaxis
treatment
... as a possible
cause
... require prolonged
treatment
... as patient is
stable
Summary of
Treatments
... Allergic #Rhinitis #
Treatments
... #Medications #
Table
CERTA Analgesic
Classes
... CERTA #Analgesic #
Classes
... Indications #Management #
Table
frequently benign
causes
... life-threatening
causes
... In many
cases
, syncope ... The
treatment
strategy ... depends on the
cause
DAAs #Antivirals #
table
... #
treatment
#hcv
. trachomatis
Pan
-Colitis ... Diagnosis #Map #
Causes
Low TSH -> TSH-R-
Ab
... Management #Algorithm #
treatment
Common Breast
Masses
... Oncology #Breast #
Masses
... #Comparison #
Table
According to Primary
Treatment
... of
Causes
and Problems ... #Differential #
Causes
Recommended 1st-line
Treatments
... ID_agram #HIV #
Treatments
... Therapy #Firstline #
Table
catheterization (
PAC
... measurements obtained by
PAC
... may benefit from
PAC
... indices measured on
PAC
... #Differential #
Table
Hemodynamically
Stable
... Management #Algorithm #
treatment
important to be
able
... suprapatellar fat
pad
... pre femoral fat
pad
... Devpriyo
Pal
@drdevrad
Vascular → PE,
PAH
... findings based on
cause
... Differential #Diagnosis #
table
scanning or CT-
PA
... are outlined in
Table
... Imaging #Comparison #
Table
#medications #
table
... #
treatment
#drugs
to looking for
causes
... medical diagrams,
tables
... #differential #
causes
Buprenorphine - Comparison
Table
... medication assisted
treatment
... In these
cases
, ... side effects are
nausea
... Hospital Opioid Use
Treatment
you think of the
causes
... or tumor cells (
Table
... the alveoli and
cause
Multiple
masses
... list of multiple
masses
... listed in the
table
... consolidations from
masses
Table
3. ... Suggested Empiric
Treatment
diagnosis #management #
treatment
... #
table
should have a
Pap
... •
Pap
test should ... 3 consecutive
Pap
... • Co-testing (
Pap
... IDSA #Prevention #
Treatment
Nausea
and Vomiting ... Gravidarum vs
Nausea
... Diagnosis, Workup and
Treatment
... OBGyn #Obstetrics #
Nausea
Drugs Used for the
Treatment
... HCQ
treatment
would ... of short term
treatment
... #Medications #
Treatment
... #Pharmacology #
Table
Hyperviscosity Syndrome -
Causes
... and
Treatment
... Hyperviscosity #Syndrome #
Causes
... Differential #Diagnosis #
Treatment
Compatibility
Table
... Antibodies: Anti-A
AB
... Compatibility #
Table
Drug
Treatment
of ... #Pharmacology #
Table
Differential #Diagnosis #
Table
... #
Causes
Causes
of Hypermagnesemia ... or enemas -
Treatment
... Hypermagnesemia #
Causes
production •
Treatment
... rapidly fatal •
Causes
... Serotonin syndrome •
Treatment
... Identify underlying
cause
... Cooling blankets can
cause
in Anaesthesia
Caused
... or iatrogenic
causes
... thoracotomy is a better
treatment
... of underlying
cause
... small volume may
cause
vary depending on
treatment
... Pharmacology #Diagnosis #
Table
Candidates for Medical
Treatment
... Hemodynamically
stable
... comply with post-
treatment
ruling out, the
causes
... require urgent
treatments
... non-neurological
causes
this interesting
case
... guide confirmatory
lab
... testing and expedite
treatment
provide the earliest
clues
... repolarization
causes
... in conduction
causes
... #Progression #
Table
If patient is
stable
... as first-line
treatment
... naloxone) films or
tab
... Buprenorphine #
Treatment
Causes
of Thrombocytosis ... effect following
treatment
... Diagnosis #Algorithm #
Causes
Causes
of Relative ... #bradycardia #
Causes
... infectiousdiseases #
table
mmol/L - Consider
cause
... and if
treatment
... - 6.4 mmol/L -
Treatment
... /L - Emergency
treatment
... Prevention - Consider
cause
commonly available
lab
... interruption per
treatment
...
table
... Perioperative #Management #
Treatment
: • Possible
Lab
... Diagnosis #Algorithm #
causes
Most common
causes
... Most common
causes
... Comparison #Features #
Table
pharmacotherapy #
table
... endocrinology #
treatment
Polyarteritis Nodosa (
PAN
... Viral replication
causes
... multiplex #
PAN
Malignant Catatonia
Cause
... Mental Status -
Treatment
BP
stable
, HR 115 ... the body louse,
causes
... The
table
below ...
Treatment
is tetracycline ... initiation of
treatment
Management
Caused
... myorhythmia OR •
PAS
-positive ... whipplei tests (
PAS
... whipplei test (
PAS
Aldosterone #Comparison #
Table
... #
Causes
Lymphoid (ALL) -
PAS
... o CML - bcr-
able
... o Other bcr-
able
patient is still
able
... to copy
Causes
... : Stroke (main
cause
Cardiovascular
Causes
... Infarction •
Stable
... / Mediastinal
Causes
... Sarcoidosis Other
Causes
... Diagnosis #Algorithm #
causes
heart disease
Causes
... full compensatory
pause
... Diagnosis: •
PAC
... A
PAC
also has a ... more intensive
treatment
High #Magnesium #
Table
... #
Causes
#Management
and suitable
treatment
... emergencies are
caused
... glucocorticoids;
treatment
... hyponatremia);
treatment
... gold standard
treatment
Differential #Diagnosis #
table
... #
causes
#ophthalmology
Causes
of Secondary ... Testing Common
causes
... Tests to evaluate
cause
... agent Uncommon
causes
... Screening #Workup #
table
recognize the
cause
... have a general
treatment
... algorithm #management #
treatment
appropriate acute
treatment
... #Medications #
Table
diagnosis The
table
... lobar pneumonia
caused
... respond to the
treatment
... #Differential #
Table
Causes
of Chronic ... Artery Disease •
Stable
... Pleural Thickening/
Masses
... Diagnosis #Algorithm #
Causes
Association, which is
classes
... sometimes advanced
treatment
... flare ups that
cause
... Classification #Stages #
Classes
oxidative iniury
Treatment
... per day until
stable
... Management #Summary #
causes
... #
treatment
Diagnosis and
Treatment
... Hyponatremia is usually
caused
... vast majority of
cases
...
Treatment
:
Treatment
... the underlying
cause
chemotherapy induced
nausea
... (postoperative
nausea
... Steroid #Conversion #
Table
Vasculitides 5% (
PAN
... hypovolemia), Meds/
Treatments
barns and lake
houses
... chills, myalgias,
nausea
... • Autopsy PCR
Treatment
... diagnosis #management #
treatment
Antibiotics used for the
Treatment
... #microbiology #
table
Causes
of Iron Deficiency ... Pregnancy, EPO
treatment
... differential #diagnosis #
causes
Stains Mycology
Lab
... Periodic acid-Schiff (
PAS
... fungus #comparison #
table
×
PAH
vs. heart failure ... #Hypertension #
PAH
... #Comparison #
Table
Summary
table
of ... medical diagrams,
tables
... #pharmacology #
table
... #medications #
treatment
Lab
patterns seen ... Metabolism A
table
... of
lab
values compiled ... Peds #Pediatrics #
Table
Comorbidities: •
Stable
... Opioid Withdrawal,
PAD
... #pharmacology #
table
Tobacco Cessation
Treatment
... , Varenicline (
tablet
... release (SR) (
tablet
... Therapy #Comparison #
Table
Treatment
Algorithm ... #Hypertension #
PAH
... #
Treatment
#Management
Pharmacologic
Treatment
... Hyperthyroidism #
Treatment
... Medications #Comparison #
Table
►
Summary
Table
of ...
Causes
of Acrocyanosis ... #Differential #
Causes
... #Diagnosis #
Causes
... #
Table
Guidelines for
Treatment
... Polyarteritis Nodosa (
PAN
... pubmed.ncbi.nlm.nih.gov/34235884/
PAN
... Vasculitis #Management #
Treatment
DOACs) for VTE
treatment
... prevention - Comparison
Table
... Pharmacology #Comparison #
Table
Occult
Causes
of ... hypotension is
treatment
... response -> cognitive
pause
... toxicologic - 2nd
cause
... #Differential #
Causes
eyelash follicle •
Cause
... , swelling •
Treatment
... upper lid •
Cause
... painless lump •
Treatment
... Chalazion #Comparison #
Table
#Differential #
Table
... #Dyspnea #SOB #
Causes
Table
of
Causes
... Liver #Injury #
Causes
... Differential #Incidence #
Table
Pharmacologic
Treatments
... Pregnancy #Management #
Treatment
... Pharmacology #HTN #
Table
ligament
PAF
... process fracture •
Par
... fractures: Don't
cause
... deficit, still
able
... Cauda equina
Treatment
Causes
of Frequency ... Nocturia #Polyuria #
Causes
... Differential #Urology #
Table
conditions all of which
cause
... different types/
causes
... RenalTubularAcidosis #Features #
Table
antibiotic in-hospital
treatment
... antibiotics #therapy #
treatment
... #
table
#duration
Causes
of Cough ... , Chemicals,
Gases
... #Differential #
Causes
... #
Table
REBEL Review 89:
Treatment
... Hemorrhage #FOAMed #
table
Room - Comparison
Table
... Labs, Imaging and
Treatment
... BiliaryDiseases #
Table
See the
lab
values ...
table
for supplemental ... Peds #Pediatrics #
Table
Antiarrhythmic Medication
Table
... #Medications #
Table
... Classification #
Classes
Differential #Diagnosis #
Table
... #
Causes
#pharmacology #
table
... comparison #drugs #
treatment
Differential #Diagnosis #
Table
... #OrganSystem #
Causes
Diagnosis of Common
Causes
... Diagnosis #Comparison #
Table
- A Comparison
Table
... Diagnosis and
Treatment
... Vein #Comparison #
Table
Causes
of Pleural ... #Differential #
Table
Clues
to Differential ... Central #Cardiology #
Causes
... #
Table
#Comparison
#Asthmaticus #
Treatment
... #Options #
Table
Drugs Used for the
Treatment
... #Medications #
Treatment
... #Pharmacology #
Table
of diseases can
cause
... headaches are
caused
... Primary #Secondary #
Table
high WBC count
cause
... or priapism •
Lab
... organ damage •
Treatment
... Low calcium •
Treatment
... - Hyperkalemia
treatment
Features of Major
Causes
... Symptoms #Comparison #
Table
Causes
of Thrombocytopenia ... practices that could
cause
... HCV testing -
Lab
... patients if the
cause
... Differential #Diagnosis #
Causes
Treatment
of Bleeding ... HemophiliaB #Management #
Table
... #
Treatment
Life Threatening
Causes
... Differential Diagnosis
Table
... differential #diagnosis #
table
Causes
, Symptoms ... Diagnosis #Comparison #
Table
►
Ab
to AChR blocks ... muscles: “myasthenic
crises
... Miller Fischer and
PCB
... - Symptomatic
Treatment
... Myasthenia
Crises
#pharmacology #
table
... comparison #management #
treatment
#Differential #
Causes
... #
Table
Reflex Testing -
Causes
... Deep coma (any
cause
... Hyperreflexia #Testing #
Causes
... differential #diagnosis #
table
Fluid in Different
Causes
... Viral #Comparison #
Table
Hypertension (
PAH
... #Hypertension #
PAH
... Management #Algorithm #
treatment
REBEL Review 71:
Treatment
... hyperthyroidism #
table
... #management #
treatment
classification Different
causes
... Tertiary #Comparison #
Table
#pharmacology #
table
... comparison #management #
treatment
Inpatient Cath
Lab
... Indications Cath
Lab
... arrhythmia Cath
lab
... -7) risk Cath
lab
... Rx: NSTEMI/UA:
stable
#management #
treatment
... #
table
#Pharmacology #
Treatment
... #
Table
#Medications
Treatment
of
Stable
... Treat underlying
cause
... Treat underlying
cause
... #
Stable
#NarrowComplex ... #Tachycardia #
Treatment
Common
Causes
of ... Lightheadedness #
Table
ILD of Known
Cause
... Pneumonitis •
Treatment
... BrighamChiefs #ILD #
Causes
Differential Diagnosis
Table
... whether AF is
cause
... Tx: Underlying
cause
... Differential #Diagnosis #
Table
... Narrow #Irregular #
causes
Table
of Weight-Loss ... the long-term
treatment
... #Pharmacology #
Table
Organisms and
Treatment
... Bacterial #Meningitis #
Causes
Syndromes - This
table
... some toxicologic
causes
... Syndromes #Comparison #
Table
#Differential #
Table
... #
Causes
#Intrahepatic
Hyperthermia (most common
cause
... No confirmatory
lab
... Cornerstone of
treatment
It is
caused
by ... actually seen in all
causes
... pneumonia, congenital
causes
... Devpriyo
Pal
@drdevrad
Causes
of AKI in ... Differential #Diagnosis #
Causes
... #
table
Polyarteritis Nodosa (
PAN
... @MithuRheum #
PAN
... Vasculitis #Management #
Treatment
Brief Overview of
Treatment
... #Medications #
Treatment
... #Pharmacology #
Table
The anterior fat
pad
... posterior fat
pad
... So even in a
case
... posterior fat
pad
... the anterior fat
pad
Diagnosis #Nephrology #
Table
... #Differential #
Causes
(from multiple
causes
... pseudofracture -
Lab
... of underlying
cause
... Osteopenia -
Lab
Differential #Diagnosis #
Causes
... #
Table
• Most common
cause
... antibiotics once
stable
... hemorrhage •
Treatment
... shows a small,
stable
... #differential #
causes
Cyanide Toxicity
Treatment
... Amyl nitrite -
causes
... Pathophysiology #Management #
Treatment
Ioxedes Tick -
Treatment
... Lone Star Tick -
Treatment
... Ioxedes Tick -
Treatment
... diagnosis #comparison #
table
Medications #Management #
Treatment
... #Pharmacology #
Table
Diagnosis and
Treatment
... of Common
Causes
Underlying
causes
... Differential #Diagnosis #
Table
the therapeutic
uses
... adrenergic agonists
Table
... and Therapeutic
Uses
... #Alpha #Beta #
Table
distinction has HUGE
treatment
... and first-line
treatment
... Comparison #Diagnosis #
Table
CAH #algorithm #
causes
... diagnosis #comparison #
treatment
Causes
of Terminal ... Vascular: SLE,
PAN
... Differential #Diagnosis #
Causes
arrest where other
causes
... trolley, anaphylaxis
treatment
... as a possible
cause
... require prolonged
treatment
... as patient is
stable
Summary of
Treatments
... Allergic #Rhinitis #
Treatments
... #Medications #
Table
CERTA Analgesic
Classes
... CERTA #Analgesic #
Classes
... Indications #Management #
Table
frequently benign
causes
... life-threatening
causes
... In many
cases
, syncope ... The
treatment
strategy ... depends on the
cause
DAAs #Antivirals #
table
... #
treatment
#hcv
. trachomatis
Pan
-Colitis ... Diagnosis #Map #
Causes
Low TSH -> TSH-R-
Ab
... Management #Algorithm #
treatment
Common Breast
Masses
... Oncology #Breast #
Masses
... #Comparison #
Table
According to Primary
Treatment
... of
Causes
and Problems ... #Differential #
Causes
Recommended 1st-line
Treatments
... ID_agram #HIV #
Treatments
... Therapy #Firstline #
Table
catheterization (
PAC
... measurements obtained by
PAC
... may benefit from
PAC
... indices measured on
PAC
... #Differential #
Table
Hemodynamically
Stable
... Management #Algorithm #
treatment
important to be
able
... suprapatellar fat
pad
... pre femoral fat
pad
... Devpriyo
Pal
@drdevrad
Vascular → PE,
PAH
... findings based on
cause
... Differential #Diagnosis #
table
scanning or CT-
PA
... are outlined in
Table
... Imaging #Comparison #
Table
#medications #
table
... #
treatment
#drugs
to looking for
causes
... medical diagrams,
tables
... #differential #
causes
Buprenorphine - Comparison
Table
... medication assisted
treatment
... In these
cases
, ... side effects are
nausea
... Hospital Opioid Use
Treatment
you think of the
causes
... or tumor cells (
Table
... the alveoli and
cause
Multiple
masses
... list of multiple
masses
... listed in the
table
... consolidations from
masses
Table
3. ... Suggested Empiric
Treatment
diagnosis #management #
treatment
... #
table
should have a
Pap
... •
Pap
test should ... 3 consecutive
Pap
... • Co-testing (
Pap
... IDSA #Prevention #
Treatment
Nausea
and Vomiting ... Gravidarum vs
Nausea
... Diagnosis, Workup and
Treatment
... OBGyn #Obstetrics #
Nausea
Drugs Used for the
Treatment
... HCQ
treatment
would ... of short term
treatment
... #Medications #
Treatment
... #Pharmacology #
Table
Hyperviscosity Syndrome -
Causes
... and
Treatment
... Hyperviscosity #Syndrome #
Causes
... Differential #Diagnosis #
Treatment
GrepMed
Sign up
Login
about
browse
contact
Support GrepMed
Welcome to GrepMed!
Sign up
to bookmark, like, and share #FOAMed images to reach an audience of
> 1 million weekly!
Sign up
×
670
results
sorted by: relevance
bookmarks
views
likes
comments
time
diagnosis
management
differential
pharmacology
clinical
comparison
algorithm
radiology
medications
cardiology
syndrome
neurology
pulmonary
hematology
rheumatology
classification
cxr
radiologyassistant
criticalcare
workup
PAH
vs. heart failure ... #Hypertension #
PAH
... #Comparison #
Table
Summary
table
of ... medical diagrams,
tables
... #pharmacology #
table
... #medications #
treatment
Lab
patterns seen ... Metabolism A
table
... of
lab
values compiled ... Peds #Pediatrics #
Table
Comorbidities: •
Stable
... Opioid Withdrawal,
PAD
... #pharmacology #
table
Tobacco Cessation
Treatment
... , Varenicline (
tablet
... release (SR) (
tablet
... Therapy #Comparison #
Table
Treatment
Algorithm ... #Hypertension #
PAH
... #
Treatment
#Management
Pharmacologic
Treatment
... Hyperthyroidism #
Treatment
... Medications #Comparison #
Table
►
Summary
Table
of ...
Causes
of Acrocyanosis ... #Differential #
Causes
... #Diagnosis #
Causes
... #
Table
Guidelines for
Treatment
... Polyarteritis Nodosa (
PAN
... pubmed.ncbi.nlm.nih.gov/34235884/
PAN
... Vasculitis #Management #
Treatment
DOACs) for VTE
treatment
... prevention - Comparison
Table
... Pharmacology #Comparison #
Table
No results found for "PAB treatment table causes"
Try removing search terms or sorting by relevance
Or
Upload an image
for you and others searching for #PAB #treatment #table #causes
![PAH vs. heart failure with preserved ejection fraction [HFpEF]
#Diagnosis #Pulmonary #Hypertension #PAH #Comparison #Table #HFpEF #DiastolicCHF](data:image/jpeg;base64,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 "PAH vs. heart failure with preserved ejection fraction [HFpEF]
#Diagnosis #Pulmonary #Hypertension #PAH #Comparison #Table #HFpEF #DiastolicCHF ...")
![Mesenteric Ischemia - Differential Diagnostic Schema
Chronic: ASCVD, Venous, Vasculitides 5% (PAN, [E]GPA, IgA, MPA)
Acute
- Venous](data:image/jpeg;base64,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 "Mesenteric Ischemia - Differential Diagnostic Schema
Chronic: ASCVD, Venous, Vasculitides 5% (PAN, [E]GPA, IgA, MPA)
Acute
- Venous ...")
